GENETIC POLYMORPHISMS OF DRUG-METABOLIZING-ENZYMES AND LUNG-CANCER SUSCEPTIBILITY

被引:49
作者
KAWAJIRI, K
WATANABE, J
EGUCHI, H
HAYASHI, S
机构
[1] Department of Biochemistry, Saitama Cancer Center Research Institute, Saitama, 362, 818 Komuro, Ina
来源
PHARMACOGENETICS | 1995年 / 5卷
关键词
D O I
10.1097/00008571-199512001-00004
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
A close association of smoking-associated lung cancer incidence with the Msp I and Ile-Val polymorphisms of CYP1A1 gene was found in a Japanese population in terms of genotype frequency comparison and cigarette dose response. A synergistic increase in susceptibility to lung cancer was observed when the susceptible genotypes of CYP1A1 were combined with a deficient GSTM1 genotype. Individual difference in expression levels of Ahr and Arnt mRNAs was observed, and the expression levels of CYP1A1 appeared to associate with those of transcriptional factors, The Ahr protein has two different structures, ascribed to one amino acid replacement at codon 554 of Arg by Lys. However, this germ line polymorphism did not show a significant association with AHH inducibility nor lung cancer incidence, The p53 gene alterations in lung cancer tissues were more frequently observed among the patients with a susceptible allele of CYP1A1 gene.
引用
收藏
页码:S70 / S73
页数:4
相关论文
共 17 条
[1]   CLONING OF THE AH-RECEPTOR CDNA REVEALS A DISTINCTIVE LIGAND-ACTIVATED TRANSCRIPTION FACTOR [J].
BURBACH, KM ;
POLAND, A ;
BRADFIELD, CA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (17) :8185-8189
[2]   RELEVANCE OF METABOLIC POLYMORPHISMS TO HUMAN CARCINOGENESIS - EVALUATION OF EPIDEMIOLOGIC EVIDENCE [J].
CAPORASO, N ;
LANDI, MT ;
VINEIS, P .
PHARMACOGENETICS, 1991, 1 (01) :4-19
[3]   CDNA CLONING AND STRUCTURE OF MOUSE PUTATIVE AH RECEPTOR [J].
EMA, M ;
SOGAWA, K ;
WATANABE, N ;
CHUJOH, Y ;
MATSUSHITA, N ;
GOTOH, O ;
FUNAE, Y ;
FUJIIKURIYAMA, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 184 (01) :246-253
[4]   GENETIC-LINKAGE OF LUNG CANCER-ASSOCIATED MSPI POLYMORPHISMS WITH AMINO-ACID REPLACEMENT IN THE HEME BINDING REGION OF THE HUMAN CYTOCHROME-P450IA1 GENE [J].
HAYASHI, S ;
WATANABE, J ;
NAKACHI, K ;
KAWAJIRI, K .
JOURNAL OF BIOCHEMISTRY, 1991, 110 (03) :407-411
[5]   INTERINDIVIDUAL DIFFERENCE IN EXPRESSION OF HUMAN AH RECEPTOR AND RELATED P450 GENES [J].
HAYASHI, S ;
WATANABE, J ;
NAKACHI, K ;
EGUCHI, H ;
GOTOH, O ;
KAWAJIRI, K .
CARCINOGENESIS, 1994, 15 (05) :801-806
[6]   HIGH SUSCEPTIBILITY TO LUNG-CANCER ANALYZED IN TERMS OF COMBINED GENOTYPES OF P450IA1 AND MU-CLASS GLUTATHIONE-S-TRANSFERASE GENES [J].
HAYASHI, S ;
WATANABE, J ;
KAWAJIRI, K .
JAPANESE JOURNAL OF CANCER RESEARCH, 1992, 83 (08) :866-870
[7]   IDENTIFICATION OF GENETICALLY HIGH-RISK INDIVIDUALS TO LUNG-CANCER BY DNA POLYMORPHISMS OF THE CYTOCHROME-P450IA1 GENE [J].
KAWAJIRI, K ;
NAKACHI, K ;
IMAI, K ;
YOSHII, A ;
SHINODA, N ;
WATANABE, J .
FEBS LETTERS, 1990, 263 (01) :131-133
[8]  
KAWAJIRI K, 1983, CRIT REV ONCOL HEMAT, V14, P77
[9]  
MANNERVIK B, 1988, CRC CRIT REV BIOCH, V23, P281
[10]  
NAKACHI K, 1991, CANCER RES, V51, P5177